mate there are some fanboys still lingering here who even with...

mate there are some fanboys still lingering here who even with the science underr peer reviewed journal gold standard imo for investing medtech imo will continue to make dumb remarks. Reverse back 3 years ago it was 100x times worse and they were praising how good management was and shre price was going to soar on next news i have alway being highly critical of management especially when new lot came 2016 and good reason as sp has depreciated by over 90% in this period . Le maitre deal was acknowledgement that their go2 market strategy was a failure after costing probably into 100 of millions and also a relatively poor deal imo. There are dozens of other glaring costly miscalculated decisions iimo. Good luck.